Current Issue June 2012, Vol. 40, No. 6

Inside this Issue

  • Functional role of UTX in normal and malignant hematopoiesis
    See Liu et al., pages 487-498..

    Ubiquitously transcribed tetratricopeptide repeat, X chromosome (UTX, also known as KDM6A), encodes an H3K27Me2/3 demethylase, which plays an important role in development, self renewal and cardiac differentiation. The UTX protein has tumor repressor properties, its deficiency results in embryonic lethality in mice, and somatic mutations have been identified in multiple hematological malignancies and many types of leukemia cell lines.

  • Improved cord blood engraftment: Ex vivo fucosylation revisited
    See Robinson et al., pages 445-456..

    Advantages to HLA-matched unrelated donor CB transplants (UCBT) include a broad source of cells from worldwide public CB banks and relatively low rates of serious graft-versus-host disease (GvHD), due to the greater HLA disparity tolerated. However, a major obstacle slowing down the broader use of UCBT in adults remains the delayed engraftment resulting in significantly increased morbidity and mortality during the immediate post transplant period.

Read full Inside this Issue

  • The HDAC Inhibitor Givinostat Modulates the Hematopoietic Transcription Factors NFE2 and C-MYB in JAK2V617F Myeloproliferative Neoplasm Cells
    10 May 2012

    Ariel Amaru Calzada, Katia Todoerti, Luca Donadoni, Anna Pellicioli, Giacomo Tuana, Raffaella Gatta, Antonino Neri, Guido Finazzi, Roberto Mantovani, Alessandro Rambaldi, Martino Introna, Luigia Lombardi, Josée Golay

  • Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase
    27 April 2012

    Ivana Hermanova, Marketa K. Zaliova, Jan Trka, Julia Starkova

  • How can we reduce hepatic veno-occlusive disease–related deaths after allogeneic stem cell transplantation?
    27 April 2012

    Douglas B. Johnson, Bipin N. Savani

  • Drug-interaction studies evaluating T-cell proliferation reveal distinct activity of dasatinib and imatinib in combination with cyclosporine A
    20 April 2012

    Stephen J. Blake, Timothy P. Hughes, A. Bruce Lyons

  • In reply
    16 April 2012

    Simon Robinson, Paul J. Simmons, Michael W. Thomas, Nathalie Brouard, Jeannie A. Javni, Suprita Trilok, Jae-Seung Shim, Hong Yang, David Steiner, William K. Decker, Dongxia Xing, Leonard D. Shultz, Barbara Savoldo, Gianpietro Dotti, Catherine M. Bollard, Leonard Miller, Richard E. Champlin, Elizabeth J. Shpall, Patrick A. Zweidler-McKay

  • View More Articles in Press...

On the Cover

Cover Image

Journal Access

Full-text articles are available from 1999 to the present. Access to abstracts is complimentary. Access to non-review full-text articles is limited to ISEH members and other subscribers.

Join ISEH and Become a Subscriber

Activate Online Access

About ISEH - Society for Hematology and Stem Cells

The mission of the ISEH - Society for Hematology and Stem Cells is to promote the scientific knowledge and clinical application of basic hematology, immunology, stem cell research, cell and gene therapy and related aspects of research through publications, discussions, scientific meetings and the support of young investigators.

Publishing Information

Experimental Hematology is published by Elsevier for the ISEH - Society for Hematology and Stem Cells.


Access this journal onSciVerse ScienceDirect
Print or Share This Page

ISEH Annual Meeting

2012

Registration and abstract submission are now open for the ISEH annual scientific meeting. The meeting will be held August 23-26 in Amsterdam. Abstracts will be published as a supplement to Experimental Hematology. We hope to see you in Amsterdam!

ISEH Member Access

For seamless access to Experimental Hematology content, ISEH members should first log into the ISEH website, then click on "Experimental Hematology."

About Experimental Hematology

Experimental Hematology publishes original research reports (regular and fast-track submissions), reviews, letters to the editor, and abstracts of the annual meeting of ISEH - Society for Hematology and Stem Cells. We welcome manuscripts describing basic in vitro and in vivo research centered on normal and malignant hematopoiesis as well as non-malignant hematologic diseases. Submissions focused on non-hematopoietic stem cells (e.g. mesenchymal stem cells, embryonic stem cells and induced pluripotent stems) with potential relevance to hematopoiesis are also welcome, as are studies involving experimental or early phase clinical cell transplantation. Studies employing genomic and systems biology approaches to the study of normal and malignant hematopoiesis are strongly encouraged, as are those employing model organisms.